InsidersTradesSigma
Follow the 레이 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 레이 has logged 141 public disclosures. Market capitalisation: €83.8bn. The latest transaction was reported on 13 July 2026 (Purchase). Among the most active insiders: 미래에셋자산운용. All data is openly available.
137
Insider Decl.
n/a
Thresholds
€3m
40 ops.
Buy Volume
€117,409
72 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,631 of 29,064 companies
53.6
score / 100
Value68
Quality40
FCF yld11%
Earn yld3.7%
EV/EBITDA9.6x
ROE1.3%
Gross mgn47%
Net mgn2.8%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations141 total
Other
Other
Other
Other
25 of 141 declarations
关于 레이
레이 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于创新医药产品的开发和商业化。